November 16, 2021
Kowa said on November 15 that it has filed a new drug application for K-924, a fixed-dose combination of its hypercholesterolemia treatment Livalo (pitavastatin) and ezetimibe, in Japan. The submission is based on data from a PIII study in Japan,...read more